Anti-Rituximab Antibodies in Primary Membranous Nephropathy: Time for Routine Monitoring in Clinical Practice?
Saved in:
| Main Authors: | Stathis Tsiakas, Stephanie Torres Rodriguez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S246802492500405X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
by: Marco Allinovi, et al.
Published: (2025-08-01) -
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01) -
WCN25-4122 Rituximab in Primary Membranous Nephropathy- three years outcome
by: Prabjot Kaur Johal, et al.
Published: (2025-02-01) -
WCN25-4036 Improved Outcomes with an Additional Rituximab Dose in Primary Membranous Nephropathy
by: Vinod Kumar, et al.
Published: (2025-02-01) -
The significance of anti-PLA2R antibody in the diagnosis and treatment of primary membranous nephropathy
by: XU Dong-mei, et al.
Published: (2019-01-01)